Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

Pfizer announced that its combination therapy of BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) has demonstrated ...

Pfizer’s Braftovi+Mektovi shows long-term clinically meaningful response in patients with BRAF V600E-mutant metastatic NSCLC: New York Monday, September 16, 2024, 10:00 Hrs [IST ...

Pfizer Inc. (PFE) announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy ...

A summary of current health news including Walgreens settling fraud charges, FDA approval for Eli Lilly's eczema drug, links ...

A summary of current health news, including a Nipah virus death in Kerala, an mpox case rise in Uganda, and Pfizer's efforts ...

Pfizer Inc. (NYSE: PFE) today announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and ...

The first rate cut from the Federal Reserve is slated for September.

With rate cuts on the way, growth and income investors should grab quality dividend stocks with high yields like these and hold them forever.

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any breaking news developments ...

The September syndrome is already visible in U.S. stock markets. September is known to be the worst-performing month for Wall ...

AstraZeneca's Imfinzi was used before and after surgery in a clinical trial of patients with muscle-invasive bladder cancer — ...